<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04318158</url>
  </required_header>
  <id_info>
    <org_study_id>FMBSUREC/08032020/Fakhry</org_study_id>
    <nct_id>NCT04318158</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Fentanyl as Adjuvants to Bupivacaine in Ultrasound Guided Transversus Abdominis Plane Block</brief_title>
  <official_title>A Comparative Study of Dexmedetomidine Versus Fentanyl as Adjuvants to Bupivacaine in Ultrasound Guided Transversus Abdominis Plane Block in Patients Undergoing Radical Cystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beni-Suef University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beni-Suef University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim and objective of this study is to compare dexmedetomidine and fentanyl as adjuvants
      to bupivacaine in ultrasound guided TAP block analgesia in patients undergoing radical
      cystectomy as regarding postoperative analgesic efficacy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Radical cystectomy with pelvic lymph node dissection is the gold standard treatment for
      muscle invasive bladder cancer and is associated with a high risk of complications.
      Management of the postoperative pain is important to decrease the length of stay in the
      hospital and the risk of morbidity. Multimodal analgesia management is utilized for pain
      observed in the postoperative period.As part of a multimodal analgesic regimen, a peripheral
      nerve block can decrease opioid consumption, providing more effective analgesia with fewer
      adverse effects.TAP block is a relatively new regional anesthesia technique that provides
      analgesia to the parietal peritoneum, as well as skin and muscles of the lower anterior
      abdominal wall. Dexmedetomidine and fentanyl have been used as adjuvants to local anesthetics
      in different surgeries to provide superior analgesia and to improve the duration of the
      block.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The time for first rescue analgesia after the TAP block.</measure>
    <time_frame>first 24 hours after block.</time_frame>
    <description>Postoperative analgesia duration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the total dose of rescue analgesia after TAP bock.</measure>
    <time_frame>first 24 hours after block.</time_frame>
    <description>Postoperative analgesia consumption.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS for pain.</measure>
    <time_frame>0, 2, 4, 6, 12 and 24 hours postoperatively.</time_frame>
    <description>Postoperative pain at rest and movement.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Group(B)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive single shot US guided TAP block using 20 ml bupivacaine 0.25% on each side.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group(BD)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive single shot US guided TAP block using 20 ml bupivacaine 0.25% + 50 µg dexmedetomedine on each side.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group(BF)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive single shot US guided TAP block using 20 ml bupivacaine 0.25% + 50 µg fentanyl on each side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>single shot US guided TAP block using 20 ml bupivacaine 0.25%.</description>
    <arm_group_label>Group(B)</arm_group_label>
    <other_name>Sunnypivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Single shot US guided TAP block using 20 ml bupivacaine 0.25% + 50 µg dexmedetomedine on each side.</description>
    <arm_group_label>Group(BD)</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Single shot US guided TAP block using 20 ml bupivacaine 0.25% + 50 µg fentanyl on each side.</description>
    <arm_group_label>Group(BF)</arm_group_label>
    <other_name>Fentanyl hameln</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both sexes.

          -  ASA grade I and II.

          -  Age between 50-70 years.

          -  Elective open radical cystectomy.

        Exclusion Criteria:

          -  Any history or signs of cardiac, hepatic and renal failure.

          -  Patients with coagulopathy or under anticoagulation therapy.

          -  Infection near the site of needle insertion.

          -  Morbid obesity (BMI&gt;40 kg/m2).

          -  History of allergic reactions to any of the study medications.

          -  Previous abdominal surgery.

          -  Patients with any neurological or neuromuscular disorder or history of seizures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 19, 2020</study_first_submitted>
  <study_first_submitted_qc>March 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2020</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beni-Suef University</investigator_affiliation>
    <investigator_full_name>Dina Mahmoud Fakhry</investigator_full_name>
    <investigator_title>Assistant Lecturer of Anesthesiology, Surgical Intensive Care and Pain Management</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Fentanyl</keyword>
  <keyword>Bupivacaine</keyword>
  <keyword>Transversus Abdominis Plane Block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

